Keyphrases
Adenosine A2A Receptor (A2AR)
100%
Alloantigen
100%
Allograft Rejection
100%
Receptor Agonist
57%
T Cells
57%
Allogeneic
28%
Knock-in Mouse Model
14%
Protein Kinase
14%
C57BL
14%
Phosphorylation
14%
Inhibitory Effect
14%
Programmed Death-ligand 1 (PD-L1)
14%
Receptor Antagonist
14%
Lymphocytes
14%
Acute Rejection
14%
Inflammatory Cytokines
14%
Activation Markers
14%
Interleukin-2
14%
Spleen
14%
Allograft Survival
14%
T Cell Proliferation
14%
Induction Therapy
14%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
14%
CD25
14%
Background Strain
14%
Receptor Knockout
14%
Organ Transplantation
14%
CD40 Ligand (CD40L)
14%
Immune Activation
14%
ZAP70
14%
In Vivo Effects
14%
RANTES
14%
Costimulatory Molecules
14%
Immunology and Microbiology
Agonist
100%
T Cell
100%
Transplant Rejection
100%
Antigen-Presenting Cell
75%
Transplant Procedure
25%
Wild Type
25%
Lymphocyte
25%
Acute Graft Rejection
25%
Allotransplantation
25%
Inflammatory Cytokine
25%
CD25
25%
Knockout Mouse
25%
CTLA-4
25%
T Cell Proliferation
25%
Organ Transplantation
25%
RANTES
25%
CD40 Ligand
25%
Medicine and Dentistry
Graft Rejection
100%
Evodenoson
85%
RANTES
14%
H-89
14%
CTLA-4
14%
CD40 Ligand
14%
Cyclic AMP Dependent Protein Kinase Inhibitor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Alloantigen
100%
Evodenoson
85%
Cyclic AMP Dependent Protein Kinase Inhibitor
14%
Cytotoxic T Lymphocyte Antigen 4
14%
RANTES
14%